NEWTOWN, Pa., Nov. 12, 2015 (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of product development and software engineering solutions, today announced that it has been named a ‘Major Contender’ on Everest Group’s PEAK Matrix™ in the report ‘Life Sciences Clinical and R&D IT Services.’
“We are pleased to be named a Major Contender on the Everest Group PEAK Matrix for Life Sciences Clinical and R&D IT Services,” said Richard Golob, Global Head of the Life Sciences Practice at EPAM. “We’re proud to serve some of the world’s largest pharmaceutical and healthcare companies, and as our life science customers continue to evolve within this hyper-connected global marketplace, EPAM is excited to play a role in driving the industry forward.”
In the Life Sciences industry, EPAM delivers a sophisticated combination of deep scientific and mathematical knowledge with superior software engineering and global deployment capabilities. EPAM delivers accelerated solutions to its clients, from research, discovery and time-to-market to improved collaboration and knowledge management.
Developed by Everest Group, a global consulting and research firm, the PEAK (Performance, Experience, Ability, Knowledge) Matrix is a framework that assesses the relative market success and overall capability of service providers in various industries. The results were published in Everest Group’s PEAK Matrix™ in the report ‘Life Sciences Clinical and R&D IT Service - Service Provider Landscape with PEAK Matrix™ Assessment 2015.’
About EPAM Systems
Established in 1993, EPAM Systems, Inc. (NYSE:EPAM) is recognized as a leader in software product development by independent research agencies. Headquartered in the United States, EPAM serves clients worldwide utilizing its award-winning global delivery platform and its locations in over 20 countries across North America, Europe, Asia and Australia. EPAM was ranked #6 in America's 25 Fastest-Growing Tech Companies and #3 in America’s Best Small Companies lists by Forbes Magazine.
For more information, please visit http://www.epam.com/.
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.
CONTACT: Danielle Ruess-Saltz